NUVL Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 12.52%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $311,936,735.90

Nuvalent Insider Trading History Chart

Nuvalent Share Price & Price History

^$90.92

▼ -1.77 (-1.91%)

As of 10/29/2024 01:00 AM ET

Days: 30 | 90 | 365

Banking failure dead ahead

From Porter & Company | Ad

If you missed it, my emergency election broadcast is now available - but will be removed soon

Click here to watch it now.

Nuvalent Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
10/22/2024	James E Flynn	Director	Sell	2,000,000	$97.75	$195,500,000.00	8,670,512
10/15/2024	James Richard Porter	CEO	Sell	27,000	$102.28	$2,761,560.00	188,113
10/1/2024	Darlene Noci	Insider	Sell	5,000	$101.74	$508,700.00	33,300
9/30/2024	Alexandra Balcom	CFO	Sell	10,000	$101.06	$1,010,600.00	33,300
9/23/2024	Matthew Shair	Director	Sell	2,000	$102.75	$205,500.00	226,522
9/16/2024	Henry E. Pelish	Insider	Sell	32,795	$98.92	$3,244,081.40	33,300
9/9/2024	Deborah Ann Miller	Insider	Sell	3,000	$88.18	$264,540.00	33,300
9/3/2024	Darlene Noci	Insider	Sell	5,000	$84.43	$422,150.00	33,300
8/30/2024	Alexandra Balcom	CFO	Sell	10,000	$84.23	$842,300.00	33,300
8/26/2024	Matthew Shair	Director	Sell	2,000	$84.46	$168,920.00	228,522
8/23/2024	Emily Conley	Director	Sell	3,334	$85.02	$283,456.68	2,507
8/23/2024	Henry E. Pelish	Insider	Sell	10,500	$85.08	$893,340.00	66,095
8/8/2024	Deborah Ann Miller	Insider	Sell	3,000	$68.78	$206,340.00	33,300
8/1/2024	Darlene Noci	Insider	Sell	5,000	$77.22	$386,100.00	33,300
7/31/2024	Alexandra Balcom	CFO	Sell	10,000	$79.51	$795,100.00	33,300
7/29/2024	Matthew Shair	Director	Sell	2,000	$79.59	$159,180.00	230,522
7/15/2024	Emily Conley	Director	Sell	5,000	$80.72	$403,600.00	2,507
7/12/2024	Deborah Ann Miller	Insider	Sell	6,000	$80.16	$480,960.00	33,300
7/8/2024	Deborah Ann Miller	Insider	Sell	3,000	$73.23	$219,690.00	33,300
7/1/2024	Darlene Noci	Insider	Sell	5,000	$75.54	$377,700.00	33,300
6/28/2024	Alexandra Balcom	CFO	Sell	10,000	$75.43	$754,300.00	33,300
6/24/2024	Matthew Shair	Director	Sell	2,000	$80.22	$160,440.00	232,522
6/14/2024	Emily Conley	Director	Sell	5,000	$77.56	$387,800.00	2,507
5/28/2024	Matthew Shair	Director	Sell	2,000	$67.22	$134,440.00	234,522
5/13/2024	Matthew Shair	Director	Sell	37,500	$65.84	$2,469,000.00	1,424,698
5/6/2024	Matthew Shair	Director	Sell	37,500	$69.48	$2,605,500.00	1,462,198
5/2/2024	Deborah Ann Miller	Insider	Sell	3,000	$72.07	$216,210.00	33,300
4/29/2024	Matthew Shair	Director	Sell	2,000	$67.51	$135,020.00	236,522
4/22/2024	Matthew Shair	Director	Sell	37,500	$63.65	$2,386,875.00	1,537,198
4/15/2024	Matthew Shair	Director	Sell	37,500	$65.56	$2,458,500.00	1,574,698
4/8/2024	Matthew Shair	Director	Sell	37,500	$68.44	$2,566,500.00	1,612,198
4/4/2024	Deborah Ann Miller	Insider	Sell	3,000	$73.60	$220,800.00	33,300
4/1/2024	Matthew Shair	Director	Sell	37,500	$76.92	$2,884,500.00	1,649,698
3/28/2024	Deborah Ann Miller	Insider	Sell	22,000	$75.20	$1,654,400.00	33,300
3/27/2024	Andrew A.F. Hack	Director	Sell	880,000	$72.77	$64,037,600.00	2,697,267
3/25/2024	Matthew Shair	Director	Sell	37,500	$76.77	$2,878,875.00	1,687,198
3/22/2024	Darlene Noci	Insider	Sell	20,000	$77.51	$1,550,200.00	33,300
12/28/2023	Matthew Shair	Director	Sell	48,548	$75.46	$3,663,432.08	1,724,698
12/26/2023	Matthew Shair	Director	Sell	69,602	$75.12	$5,228,502.24	1,774,246
12/18/2023	Alexandra Balcom	CFO	Sell	30,000	$75.82	$2,274,600.00
12/18/2023	Anna Protopapas	Director	Sell	5,000	$75.67	$378,350.00
12/18/2023	Darlene Noci	insider	Sell	40,000	$75.82	$3,032,800.00
11/28/2023	Matthew Shair	Director	Sell	9,150	$61.89	$566,293.50	1,843,848
11/1/2023	Darlene Noci	insider	Sell	3,000	$52.66	$157,980.00
10/24/2023	Matthew Shair	Director	Sell	91,700	$50.70	$4,649,190.00	1,852,998
10/4/2023	Christopher Durant Turner	Insider	Sell	7,995	$54.04	$432,049.80	14,513
10/2/2023	Darlene Noci	insider	Sell	3,000	$45.88	$137,640.00
9/15/2023	Deborah Ann Miller	insider	Sell	2,000	$47.64	$95,280.00
9/1/2023	Darlene Noci	insider	Sell	3,000	$46.56	$139,680.00
8/1/2023	Darlene Noci	insider	Sell	3,000	$49.95	$149,850.00
7/28/2023	Christopher Durant Turner	Insider	Sell	2,665	$48.93	$130,398.45	14,513
7/26/2023	Christopher Durant Turner	Insider	Sell	2,365	$46.85	$110,800.25	14,513
7/24/2023	Christopher Durant Turner	Insider	Sell	200	$46.82	$9,364.00	14,513
7/19/2023	Darlene Noci	insider	Sell	4,559	$45.04	$205,337.36	14,513
7/17/2023	Deborah Ann Miller	insider	Sell	2,000	$43.06	$86,120.00
7/3/2023	Darlene Noci	insider	Sell	3,000	$41.48	$124,440.00
6/15/2023	Darlene Noci	insider	Sell	1,000	$45.07	$45,070.00
6/5/2023	Christopher Durant Turner	Insider	Sell	10,235	$44.86	$459,142.10	14,513
6/1/2023	Darlene Noci	insider	Sell	3,000	$42.64	$127,920.00
5/15/2023	Deborah Ann Miller	insider	Sell	2,000	$40.74	$81,480.00
5/9/2023	Deborah Ann Miller	insider	Sell	1,332	$39.63	$52,787.16
5/5/2023	Deborah Ann Miller	insider	Sell	2,800	$39.64	$110,992.00
5/1/2023	Darlene Noci	insider	Sell	3,000	$38.60	$115,800.00
4/17/2023	Deborah Ann Miller	insider	Sell	2,000	$30.10	$60,200.00
4/3/2023	Darlene Noci	insider	Sell	3,000	$26.59	$79,770.00
1/17/2023	Deborah Ann Miller	insider	Sell	2,000	$32.62	$65,240.00
1/4/2023	Matthew Shair	Director	Sell	18,300	$28.04	$513,132.00	1,944,698
12/15/2022	Deborah Ann Miller	insider	Sell	2,000	$29.98	$59,960.00
12/7/2022	Matthew Shair	Director	Sell	18,300	$31.17	$570,411.00	1,962,998
11/15/2022	Deborah Ann Miller	insider	Sell	2,000	$31.91	$63,820.00
11/2/2022	Matthew Shair	Director	Sell	95,455	$32.04	$3,058,378.20	2,019,237
10/28/2022	Darlene Noci	insider	Sell	1,000	$40.25	$40,250.00
10/14/2022	Darlene Noci	insider	Sell	4,200	$21.41	$89,922.00
10/7/2022	Matthew Shair	Director	Sell	12,613	$18.70	$235,863.10	2,114,692
10/5/2022	Matthew Shair	Director	Sell	7,884	$19.22	$151,530.48	2,135,913
9/15/2022	Darlene Noci	insider	Sell	4,200	$18.14	$76,188.00
9/14/2022	Matthew Shair	Director	Sell	13,151	$18.36	$241,452.36	2,149,447
8/24/2022	Darlene Noci	insider	Sell	1,604	$17.03	$27,316.12
7/18/2022	Darlene Noci	insider	Sell	100	$17.07	$1,707.00
7/15/2022	Darlene Noci	insider	Sell	3,782	$17.29	$65,390.78
7/15/2022	Matthew Shair	Director	Sell	2,000	$18.29	$36,580.00	2,162,598
7/13/2022	Matthew Shair	Director	Sell	100	$18.25	$1,825.00	2,164,598
7/7/2022	Darlene Noci	insider	Sell	16,800	$17.61	$295,848.00
2/15/2022	Darlene Noci	Insider	Sell	4,200	$17.17	$72,114.00

Urgent: This election is rigged

From Porter & Company | Ad

If you missed it, my emergency election broadcast is now available - but will be removed soon

Click here to watch it now.

SEC Filings (Institutional Ownership Changes) for Nuvalent (NASDAQ:NUVL)

97.26% of Nuvalent stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Nuvalent Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
10/29/2024	Harbor Capital Advisors Inc.	21,516	$2.20M	0.1%	+29.9%	0.033%
10/25/2024	China Universal Asset Management Co. Ltd.	11,417	$1.17M	0.1%	+64.4%	0.018%
10/25/2024	abrdn plc	47,460	$4.86M	0.0%	-45.9%	0.073%
10/23/2024	Mirae Asset Global Investments Co. Ltd.	2,147	$0.21M	0.0%	+21.6%	0.003%
10/11/2024	Creative Planning	2,267	$0.23M	0.0%	N/A	0.004%
10/10/2024	Exchange Traded Concepts LLC	1,493	$0.15M	0.0%	-41.9%	0.002%
10/5/2024	Handelsbanken Fonder AB	9,300	$0.95M	0.0%	+20.8%	0.014%
10/3/2024	SG Americas Securities LLC	7,385	$0.76M	0.0%	+120.1%	0.011%
8/16/2024	Perceptive Advisors LLC	2,549,077	$193.37M	4.6%	-8.4%	3.949%
8/16/2024	Algert Global LLC	2,954	$0.22M	0.0%	N/A	0.005%
8/16/2024	Driehaus Capital Management LLC	696,607	$52.85M	0.5%	+3.5%	1.079%
8/15/2024	The Manufacturers Life Insurance Company	22,795	$1.73M	0.0%	-16.5%	0.035%
8/15/2024	D. E. Shaw & Co. Inc.	399,199	$30.28M	0.0%	-10.4%	0.618%
8/15/2024	AQR Capital Management LLC	13,364	$1.01M	0.0%	-39.7%	0.021%
8/15/2024	Affinity Asset Advisors LLC	200,000	$15.17M	1.7%	+33.3%	0.310%
8/14/2024	Squarepoint Ops LLC	77,099	$5.85M	0.0%	+62.2%	0.119%
8/14/2024	Fred Alger Management LLC	578,130	$43.86M	0.2%	+6.2%	0.896%
8/14/2024	Marshall Wace LLP	84,081	$6.38M	0.0%	+1,127.1%	0.130%
8/14/2024	Samlyn Capital LLC	229,325	$17.40M	0.3%	N/A	0.355%
8/14/2024	Logos Global Management LP	195,000	$14.79M	1.2%	N/A	0.302%
8/14/2024	Bank of Montreal Can	77,755	$6.29M	0.0%	-60.0%	0.120%
8/14/2024	HighVista Strategies LLC	28,698	$2.18M	0.8%	-52.2%	0.044%
8/14/2024	ProShare Advisors LLC	7,210	$0.55M	0.0%	-18.8%	0.011%
8/14/2024	Profund Advisors LLC	12,124	$0.92M	0.0%	-28.8%	0.019%
8/13/2024	Sei Investments Co.	28,441	$2.16M	0.0%	-8.4%	0.044%
8/13/2024	Public Employees Retirement Association of Colorado	2,875	$0.22M	0.0%	N/A	0.004%
8/12/2024	Seven Eight Capital LP	6,286	$0.48M	0.0%	-59.7%	0.010%
8/12/2024	Hsbc Holdings PLC	2,701	$0.20M	0.0%	-31.2%	0.004%
8/12/2024	Amalgamated Bank	1,105	$84K	0.0%	+21.8%	0.002%
8/12/2024	E Fund Management Co. Ltd.	3,929	$0.30M	0.0%	-23.5%	0.006%
8/9/2024	Edgestream Partners L.P.	15,695	$1.19M	0.1%	N/A	0.024%
8/9/2024	Dimensional Fund Advisors LP	348,089	$26.41M	0.0%	+80.5%	0.539%
8/8/2024	First Turn Management LLC	252,276	$19.14M	3.1%	-5.1%	0.391%
8/8/2024	Nicholas Investment Partners LP	125,495	$9.52M	1.0%	+2.2%	0.194%
8/6/2024	Quest Partners LLC	574	$44K	0.0%	N/A	0.001%
8/6/2024	Candriam S.C.A.	262,008	$19.88M	0.1%	-7.7%	0.406%
8/5/2024	Arizona State Retirement System	8,215	$0.62M	0.0%	+15.9%	0.013%
8/5/2024	Victory Capital Management Inc.	172,629	$13.10M	0.0%	-2.1%	0.267%
8/1/2024	Rhumbline Advisers	46,611	$3.54M	0.0%	+18.9%	0.072%
7/31/2024	Commonwealth Equity Services LLC	4,404	$0.33M	0.0%	+62.0%	0.007%
7/29/2024	Principal Financial Group Inc.	6,324	$0.48M	0.0%	-35.3%	0.010%
7/26/2024	Bank of New York Mellon Corp	137,883	$10.46M	0.0%	+23.2%	0.214%
7/20/2024	China Universal Asset Management Co. Ltd.	6,945	$0.53M	0.1%	-38.3%	0.011%
7/12/2024	SG Americas Securities LLC	3,356	$0.26M	0.0%	+108.3%	0.005%
7/11/2024	Renaissance Capital LLC	28,481	$2.16M	1.2%	+64.4%	0.044%
7/9/2024	Harbor Capital Advisors Inc.	16,559	$1.26M	0.1%	-12.7%	0.026%
5/28/2024	Teachers Retirement System of The State of Kentucky	2,924	$0.22M	0.0%	-81.9%	0.005%
5/17/2024	Ikarian Capital LLC	101,601	$7.63M	0.8%	-67.7%	0.159%
5/16/2024	California State Teachers Retirement System	25,917	$1.95M	0.0%	-4.7%	0.040%
5/16/2024	Bain Capital Life Sciences Investors LLC	2,697,267	$202.54M	16.3%	-24.6%	4.210%
5/15/2024	Darwin Global Management Ltd.	1,436,964	$107.90M	14.6%	+2,390.5%	2.243%
5/15/2024	Mount Yale Investment Advisors LLC	2,687	$0.20M	0.0%	N/A	0.004%
5/15/2024	Price T Rowe Associates Inc. MD	858,161	$64.44M	0.0%	-22.4%	1.339%
5/15/2024	Affinity Asset Advisors LLC	150,000	$11.26M	1.4%	-14.3%	0.234%
5/14/2024	EntryPoint Capital LLC	329	$25K	0.0%	-62.7%	0.001%
5/13/2024	Seven Eight Capital LP	15,606	$1.17M	0.1%	N/A	0.024%
5/10/2024	Vanguard Group Inc.	3,412,072	$256.21M	0.0%	+2.2%	5.326%
5/9/2024	Lord Abbett & CO. LLC	452,192	$33.96M	0.1%	-0.4%	0.706%
5/8/2024	ProShare Advisors LLC	8,884	$0.67M	0.0%	+10.3%	0.014%
5/7/2024	Sei Investments Co.	31,062	$2.34M	0.0%	+5.7%	0.048%
5/7/2024	Swiss National Bank	50,900	$3.82M	0.0%	+0.8%	0.079%
5/7/2024	SG Americas Securities LLC	1,611	$0.12M	0.0%	N/A	0.003%
5/1/2024	Capstone Investment Advisors LLC	9,760	$0.73M	0.0%	+20.9%	0.015%
5/1/2024	Mirae Asset Global Investments Co. Ltd.	13,911	$1.05M	0.0%	-21.8%	0.022%
4/30/2024	Allspring Global Investments Holdings LLC	2,235	$0.17M	0.0%	+9.2%	0.003%
4/29/2024	China Universal Asset Management Co. Ltd.	11,262	$0.85M	0.1%	+70.1%	0.018%
4/18/2024	Allspring Global Investments Holdings LLC	2,235	$0.17M	0.0%	+9.2%	0.003%
4/9/2024	Renaissance Capital LLC	17,327	$1.30M	0.7%	N/A	0.027%
3/11/2024	Vanguard Group Inc.	3,339,850	$245.78M	0.0%	+56.5%	5.333%
3/5/2024	Wellington Management Group LLP	1,013,402	$74.58M	0.0%	-34.9%	1.618%
2/26/2024	Teachers Retirement System of The State of Kentucky	16,118	$1.19M	0.0%	-18.9%	0.026%
2/26/2024	Perceptive Advisors LLC	2,917,991	$214.74M	4.8%	+18.5%	4.659%
2/15/2024	Old Well Partners LLC	4,100	$0.30M	0.3%	-29.3%	0.007%
2/15/2024	Parkman Healthcare Partners LLC	59,867	$4.41M	0.6%	N/A	0.096%
2/15/2024	Boxer Capital LLC	1,120,192	$82.44M	4.1%	-7.4%	1.789%
2/14/2024	Commodore Capital LP	1,331,037	$97.95M	8.7%	+60.6%	2.125%
2/14/2024	Avoro Capital Advisors LLC	178,921	$13.17M	0.2%	-78.0%	0.286%
2/14/2024	Ghisallo Capital Management LLC	50,000	$3.68M	0.4%	N/A	0.080%
2/14/2024	Vestal Point Capital LP	200,000	$14.72M	1.6%	N/A	0.319%
2/13/2024	Affinity Asset Advisors LLC	175,000	$12.88M	2.4%	+250.0%	0.279%
2/13/2024	Rafferty Asset Management LLC	127,046	$9.35M	0.0%	+32.7%	0.203%
2/13/2024	Rhenman & Partners Asset Management AB	112,929	$8.31M	0.8%	+31.3%	0.180%
2/12/2024	Harvest Investment Services LLC	4,500	$0.33M	0.2%	N/A	0.007%
2/12/2024	Capstone Investment Advisors LLC	8,075	$0.59M	0.0%	+15.4%	0.013%
2/12/2024	TD Asset Management Inc	54,478	$4.01M	0.0%	+19.7%	0.087%
2/9/2024	Franklin Resources Inc.	175,436	$12.91M	0.0%	+13.9%	0.280%
2/8/2024	Nicholas Investment Partners LP	79,200	$5.83M	0.7%	-70.5%	0.126%
2/8/2024	First Turn Management LLC	255,897	$18.83M	2.7%	N/A	0.409%
2/7/2024	Principal Financial Group Inc.	9,774	$0.72M	0.0%	+1.4%	0.016%
2/7/2024	Dimensional Fund Advisors LP	283,820	$20.89M	0.0%	+6.9%	0.453%
2/7/2024	E Fund Management Co. Ltd.	6,798	$0.50M	0.0%	+38.3%	0.011%
2/6/2024	Charles Schwab Investment Management Inc.	236,881	$17.43M	0.0%	+19.6%	0.378%
2/6/2024	M&T Bank Corp	8,650	$0.64M	0.0%	-28.7%	0.014%
2/6/2024	Amalgamated Bank	3,815	$0.28M	0.0%	+8.1%	0.006%
2/6/2024	Swiss National Bank	50,500	$3.72M	0.0%	+11.7%	0.081%
2/5/2024	Victory Capital Management Inc.	185,121	$13.62M	0.0%	-11.4%	0.296%
2/1/2024	New York State Common Retirement Fund	22,154	$1.63M	0.0%	+9.6%	0.035%
2/1/2024	Handelsbanken Fonder AB	5,400	$0.40M	0.0%	N/A	0.009%
1/30/2024	Zurcher Kantonalbank Zurich Cantonalbank	5,417	$0.40M	0.0%	+40.7%	0.009%
1/30/2024	Strs Ohio	7,100	$0.52M	0.0%	+82.1%	0.011%

Data available starting January 2016

Nuvalent, Inc., a clinical stage biopharmaceutical company, engages in the development of therapies for patients with cancer. Its lead product candidates are NVL-520, a novel ROS1-selective inhibitor to address the clinical challenges of emergent treatment resistance, central nervous system (CNS)-related adverse events, and brain metastases that may limit the use of ROS1 tyrosine kinase inhibitors (TKIs) for patients with ROS proto-oncogene 1 (ROS1)-positive non-small cell lung cancer (NSCLC) which is under the phase 2 portion of the ARROS-1 Phase 1/2 clinical trial; NVL-655, a brain-penetrant ALK-selective inhibitor, to address the clinical challenges of emergent treatment resistance, CNS-related adverse events, and brain metastases that might limit the use of first-, second-, and third-generation ALK inhibitors that is under the phase 2 portion of the ALKOVE-1 Phase 1/2 clinical trial; and NVL-330, a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to treat tumors driven by HER2ex20, brain metastases, and avoiding treatment-limiting adverse events including due to off-target inhibition of wild-type EGFR, which is expected to initiate phase 1 trial. The company was incorporated in 2017 and is headquartered in Cambridge, Massachusetts.

Today's Range

Now: $90.92

$90.72

$92.89

50 Day Range

MA: $95.55

$81.68

$112.17

52 Week Range

Now: $90.92

$49.02

$113.51

Volume

426,066 shs

Average Volume

437,779 shs

Market Capitalization

$5.89 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.29

Who are the company insiders with the largest holdings of Nuvalent?: Nuvalent's top insider shareholders include:
James E Flynn (Director)
Andrew A F Hack (Director)
Matthew Shair (Director)
James Richard Porter (CEO)
Henry E Pelish (Insider)
Alexandra Balcom (CFO)
Darlene Noci (Insider)
Deborah Ann Miller (Insider)
Christopher Durant Turner (Insider)
Emily Conley (Director)
Anna Protopapas (Director)
Learn More about top insider investors at Nuvalent.
Who are the major institutional investors of Nuvalent?: Nuvalent's top institutional shareholders include:
abrdn plc — 0.07%
Harbor Capital Advisors Inc. — 0.03%
China Universal Asset Management Co. Ltd. — 0.02%
Handelsbanken Fonder AB — 0.01%
SG Americas Securities LLC — 0.01%
Creative Planning — 0.00%
Learn More about top institutional investors of Nuvalent stock.
Which institutional investors are selling Nuvalent stock?: Within the previous quarter, NUVL stock was sold by these institutional investors:
abrdn plc
Exchange Traded Concepts LLC
In the previous year, company insiders that have sold Nuvalent company stock include:
James E Flynn (Director)
Andrew A F Hack (Director)
Matthew Shair (Director)
James Richard Porter (CEO)
Henry E Pelish (Insider)
Alexandra Balcom (CFO)
Darlene Noci (Insider)
Deborah Ann Miller (Insider)
Christopher Durant Turner (Insider)
Emily Conley (Director)
Learn More investors selling Nuvalent stock.
Which institutional investors are buying Nuvalent stock?: In the previous quarter, NUVL stock was acquired by institutional investors including:
Harbor Capital Advisors Inc.
China Universal Asset Management Co. Ltd.
SG Americas Securities LLC
Creative Planning
Handelsbanken Fonder AB
Mirae Asset Global Investments Co. Ltd.